Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of December 2019, with a specific reporting date of December 18, 2019. The document serves as a transaction notification regarding dealings in the company's ordinary shares by Persons Discharging Managerial Responsibilities (PDMR) and persons closely associated with them.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It is strictly a regulatory disclosure of share transactions.
Material Changes
No material changes to the company's financial position or operations are reported in this document. The filing details a specific share transfer event:
- Transaction Date: December 17, 2019
- Instrument: 49,453 Ordinary Shares of 25 pence each (ISIN: GB0009252882)
- Parties Involved: Mr. P Thomson (President, Global Affairs) and Ms. K Thomson (Person Closely Associated).
- Nature of Transaction: Transfer of shares between accounts and to a spouse for nil consideration.
- Price: £0.00 per share.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, contingencies, or details on unusual items. The document is limited to the statutory notification of the share transfer described above.
Investor Verification Checklist
- Verify the total shareholding of Mr. P Thomson and Ms. K Thomson post-transaction to assess insider ownership levels.
- Confirm that the nil consideration transfer aligns with the company's internal policies regarding spousal transfers.
- Note that this filing contains no operational or financial updates; refer to the most recent Form 20-F or quarterly reports for financial performance.